KR880700670A - 알파-msh의 동족체의 국소적용으로 메라노싸이트를 자극시키는 방법 및 이에 사용될 수 있는 조성물 - Google Patents

알파-msh의 동족체의 국소적용으로 메라노싸이트를 자극시키는 방법 및 이에 사용될 수 있는 조성물

Info

Publication number: KR880700670A
Authority: KR; South Korea
Prior art keywords: stimulating; alpha; compositions; msh; topical application
Prior art date: 1986-02-03

Application number

KR1019870700899A

Other languages

English (en)

Other versions

KR900005903B1 (ko

Inventor

쥬니어 허비 빅터

이.하드레이 멕

도르 로버트

레빈 노르만

Original Assignee

유니버시티 페이턴츠 아이엔씨

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-02-03

Filing date

1987-10-03

Publication date

1988-04-11

1987-01-23 Application filed by 유니버시티 페이턴츠 아이엔씨 filed Critical 유니버시티 페이턴츠 아이엔씨

1988-04-11 Publication of KR880700670A publication Critical patent/KR880700670A/ko

1990-08-16 Application granted granted Critical

1990-08-16 Publication of KR900005903B1 publication Critical patent/KR900005903B1/ko

Links

239000000203 mixture Substances 0.000 title abstract 2
230000004936 stimulating effect Effects 0.000 title abstract 2
230000000699 topical effect Effects 0.000 title abstract 2
WHNFPRLDDSXQCL-UAZQEYIDSA-N α-msh Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(N)=O)NC(=O)[C@H](CO)NC(C)=O)C1=CC=C(O)C=C1 WHNFPRLDDSXQCL-UAZQEYIDSA-N 0.000 title abstract 2
102400000740 Melanocyte-stimulating hormone alpha Human genes 0.000 title 1
101710200814 Melanotropin alpha Proteins 0.000 title 1
210000002752 melanocyte Anatomy 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/04—Preparations for care of the skin for chemically tanning the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- A61K38/34—Melanocyte stimulating hormone [MSH], e.g. alpha- or beta-melanotropin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Zoology (AREA)
Endocrinology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Gastroenterology & Hepatology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Birds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

KR1019870700899A 1986-02-03 1987-01-23 알파-msh의 동족체의 국소적용으로 메라노싸이트를 자극시키는 방법 및 이에 사용될 수 있는 조성물 KR900005903B1 (ko)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US82516286A	1986-02-03	1986-02-03
US825,162		1986-02-03
PCT/US1987/000226 WO1987004623A1 (en)	1986-02-03	1987-01-23	Method of stimulating melanocytes by topical application of analogs of alpha-msh, and compositions for use in same

Publications (2)

Publication Number	Publication Date
KR880700670A true KR880700670A (ko)	1988-04-11
KR900005903B1 KR900005903B1 (ko)	1990-08-16

Family

ID=25243274

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
KR1019870700899A KR900005903B1 (ko)	1986-02-03	1987-01-23	알파-msh의 동족체의 국소적용으로 메라노싸이트를 자극시키는 방법 및 이에 사용될 수 있는 조성물

Country Status (11)

Country	Link
US (2)	US4918055A (ko)
EP (1)	EP0259440B1 (ko)
KR (1)	KR900005903B1 (ko)
AT (1)	ATE84420T1 (ko)
AU (1)	AU597630B2 (ko)
CA (1)	CA1282324C (ko)
DE (1)	DE3783541T2 (ko)
DK (1)	DK518187A (ko)
IE (1)	IE60883B1 (ko)
NZ (1)	NZ233248A (ko)
WO (1)	WO1987004623A1 (ko)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0293837B1 (en) *	1987-06-01	1992-01-15	Keikichi Sugiyama	Composition for application to hair or scalp
US5049547A (en) *	1988-02-11	1991-09-17	University Patents, Inc.	Composition for stimulating integumental melanocytes
US4874744A (en) *	1989-03-13	1989-10-17	University Of Cincinnati	Method of using melanocyte stimulating hormone as dermatis treatment
EP0389950A1 (en) *	1989-03-23	1990-10-03	Lion Corporation	Melanocyte-stimulating hormone inhibitor and external preparation containing the same
US5470577A (en) *	1993-07-07	1995-11-28	Trustees Of Boston University	Stimulation of tanning by DNA fragments or single-stranded DNA
US5726156A (en) *	1995-03-06	1998-03-10	Trega Biosciences, Inc.	Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels
US5420109A (en) *	1993-11-12	1995-05-30	Houghten Pharmaceuticals, Inc.	Cytokine restraining agents
US5786332A (en) *	1995-03-06	1998-07-28	Trega Biosciences, Inc.	Cytokine restraining agents and methods of use in pathologies and conditions associated with altered cytokine levels
US6001812A (en) *	1995-04-28	1999-12-14	Societe L'oreal S.A.	Modulating body/cranial hair growth with derivatives of the α-type melanocyte-stimulating hormone
FR2733421B1 (fr) *	1995-04-28	1997-06-06	Oreal	Utilisation de derives de l'hormone stimulatrice des melanocytes de type alpha pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
US5767152A (en) *	1995-05-04	1998-06-16	Nielsen; Thor Bagger	Composition and methods for stimulating hair growth
GB9801191D0 (en) *	1998-01-20	1998-03-18	Unilever Plc	Skin and hair darkening composition
US6696417B1 (en)	1997-11-21	2004-02-24	Chesebrough-Pond's Usa Co., Division Of Conopco, Inc.	Skin and hair darkening composition
US6603058B1 (en)	1998-12-09	2003-08-05	Oklahoma Medical Research Foundation	Non-human animal model for obesity and uses thereof
US6716810B1 (en)	1998-12-09	2004-04-06	Eleanor Roosevelt Institute	Composition and method for regulation of body weight and associated conditions
EP1150570B1 (en) *	1999-01-22	2006-07-12	The Schepens Eye Research Institute, Inc.	Activation of regulatory t cells by alpha-melanocyte stimulating hormone
US6800291B1 (en) *	1999-03-24	2004-10-05	Zengen, Inc.	Uro-genital condition treatment system
US7402559B2 (en)	1999-03-24	2008-07-22	Msh Pharma, Incorporated	Composition and method of treatment for urogenital conditions
AU3629300A (en) *	1999-03-24	2000-10-23	Zengen, Inc.	Antimicrobial amino acid sequences derived from alpha-melanocyte-stimulating hormone
AU2001275930B2 (en) *	2000-07-14	2007-05-10	Eisai Inc.	Alpha-msh related compounds and methods of use
CA2475985A1 (en) *	2002-02-26	2003-09-04	The Arizona Board Of Regents On Behalf Of The University Of Arizona	Method of stimulation of melanin production and induction of skin tanning
DE10228837B4 (de) *	2002-06-27	2016-01-07	Elfriede Rauch	Hautkosmetische Zusammensetzung und Verwendung der Zusammensetzung als Hautbräunungsmittel
US7745408B2 (en)	2003-11-24	2010-06-29	Clinuvel Pharmaceuticals Limited	Method of inducing melanogenesis in humans with MC1R variant alleles
DK1789076T3 (en) *	2004-08-04	2016-04-11	Clinuvel Pharmaceuticals Ltd	METHODS for inducing melanogenesis in a subject
EP2939686A1 (en)	2004-10-08	2015-11-04	Clinuvel Pharmaceuticals Limited	Compositions and methods for inducing melanogenesis in a subject
US7910101B2 (en)	2004-10-25	2011-03-22	Centocor, Inc.	Melanocortin receptor binding mimetibodies, compositions, methods and uses
MX2007004676A (es)	2004-10-27	2007-11-14	Univ Denver	Analogos de la hormona adrenocorticotropica y metodos relacionados.
WO2008015342A2 (fr) *	2006-08-03	2008-02-07	Societe D'extraction Des Principes Actifs Sa (Vincience)	Utilisation d'un extrait vegetal en tant qu'agent actif pour augmenter la synthese de melanine dans les melanocytes
ZA200901365B (en)	2006-08-28	2010-05-26	Clinuvel Pharmaceuticals Ltd	Method for reducing incidence or rate of development of skin cancers and related conditions
ES2646049T3 (es) *	2006-08-31	2017-12-11	Clinuvel Pharmaceuticals Limited	Derivados de alfa-MSH para el tratamiento de fotodermatosis
RU2009117828A (ru) *	2006-10-13	2010-11-20	Релайанс Лайф Сайенсиз Пвт. Лтд. (In)	Культивированные меланоциты на биополимерах
SI2957292T1 (en) *	2008-03-27	2018-04-30	Clinuvel Pharmaceuticals Limited	Vitiligo therapy
CA2733790A1 (en)	2008-08-20	2010-02-25	Ensemble Discovery Corporation	Macrocyclic compounds for inhibition of tumor necrosis factor alpha
US9402877B2 (en)	2011-11-04	2016-08-02	Xion Pharmaceuticals Corporation	Methods and compositions for oral administration of melanocortin receptor agonist compounds
US9610461B2 (en)	2012-03-15	2017-04-04	Galderma Research & Development	Combination of a MC1R receptor agonist and UVB for the treatment and/or prevention of pigmentation disorders
US20140271937A1 (en)	2013-03-13	2014-09-18	Transdermal Biotechnology, Inc.	Brain and neural treatments comprising peptides and other compositions
US9295636B2 (en)	2013-03-13	2016-03-29	Transdermal Biotechnology, Inc.	Wound healing using topical systems and methods
US9320758B2 (en)	2013-03-13	2016-04-26	Transdermal Biotechnology, Inc.	Brain and neural treatments comprising peptides and other compositions
US9314433B2 (en)	2013-03-13	2016-04-19	Transdermal Biotechnology, Inc.	Methods and systems for treating or preventing cancer
US9320706B2 (en)	2013-03-13	2016-04-26	Transdermal Biotechnology, Inc.	Immune modulation using peptides and other compositions
US9314423B2 (en)	2013-03-13	2016-04-19	Transdermal Biotechnology, Inc.	Hair treatment systems and methods using peptides and other compositions
US9393264B2 (en)	2013-03-13	2016-07-19	Transdermal Biotechnology, Inc.	Immune modulation using peptides and other compositions
US20140271742A1 (en) *	2013-03-13	2014-09-18	Transdermal Biotechnology, Inc.	Skin tanning using peptides and other compositions
US20140271938A1 (en)	2013-03-13	2014-09-18	Transdermal Biotechnology, Inc.	Systems and methods for delivery of peptides
US9687520B2 (en)	2013-03-13	2017-06-27	Transdermal Biotechnology, Inc.	Memory or learning improvement using peptide and other compositions
US20140271731A1 (en)	2013-03-13	2014-09-18	Transdermal Biotechnology, Inc.	Cardiovascular disease treatment and prevention
US9393265B2 (en)	2013-03-13	2016-07-19	Transdermal Biotechnology, Inc.	Wound healing using topical systems and methods
US9724419B2 (en)	2013-03-13	2017-08-08	Transdermal Biotechnology, Inc.	Peptide systems and methods for metabolic conditions
US9339457B2 (en)	2013-03-13	2016-05-17	Transdermal Biotechnology, Inc.	Cardiovascular disease treatment and prevention
US9295647B2 (en)	2013-03-13	2016-03-29	Transdermal Biotechnology, Inc.	Systems and methods for delivery of peptides
US9241899B2 (en)	2013-03-13	2016-01-26	Transdermal Biotechnology, Inc.	Topical systems and methods for treating sexual dysfunction
US9387159B2 (en)	2013-03-13	2016-07-12	Transdermal Biotechnology, Inc.	Treatment of skin, including aging skin, to improve appearance
US9849160B2 (en)	2013-03-13	2017-12-26	Transdermal Biotechnology, Inc.	Methods and systems for treating or preventing cancer
US9295637B2 (en)	2013-03-13	2016-03-29	Transdermal Biotechnology, Inc.	Compositions and methods for affecting mood states
US9314422B2 (en)	2013-03-13	2016-04-19	Transdermal Biotechnology, Inc.	Peptide systems and methods for metabolic conditions
US9750787B2 (en)	2013-03-13	2017-09-05	Transdermal Biotechnology, Inc.	Memory or learning improvement using peptide and other compositions
US9314417B2 (en)	2013-03-13	2016-04-19	Transdermal Biotechnology, Inc.	Treatment of skin, including aging skin, to improve appearance
WO2015063099A1 (en)	2013-10-28	2015-05-07	Clinuvel Ag	Alpha-msh analogues for use in the treatment of hailey-hailey disease
WO2015063102A1 (en)	2013-10-28	2015-05-07	Clinuvel Ag	Alpha-msh analogues for use in bullous disease
WO2015067503A1 (en)	2013-11-07	2015-05-14	Clinuvel Ag	Alpha-msh analogues for use in the treatment of psoriasis
US11202820B2 (en)	2014-09-25	2021-12-21	Nanyang Technological University	Targeting of melanocytes for delivering therapeutic or diagnostic agents using protein nanocages
US20170360896A1 (en)	2014-10-28	2017-12-21	Clinuvel Ag	Inflammatory disease
US20170304406A1 (en)	2014-10-28	2017-10-26	Clinuvel Ag	New indication for alpha-msh analogues
WO2016195476A1 (en)	2015-05-29	2016-12-08	Erasmus University Medical Center Rotterdam	Treatment of cardiac arrhythmias
CN106265134B (zh) *	2016-03-17	2019-02-19	哈尔滨源茂达生物技术有限公司	一种多肽美白修复精华液及其制备方法
WO2018142318A1 (en)	2017-02-01	2018-08-09	Clinuvel Pharmaceuticals Ltd	Alpha-msh analogues used in the treatment of xeroderma pigmentosum

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2158123A1 (de) *	1970-12-02	1972-06-08	Ciba-Geigy Ag, Basel (Schweiz)	Neue pharmazeutische Präparate
US4457864A (en) *	1981-10-23	1984-07-03	University Patents, Inc.	Synthetic analogues of α-melanotropin
US4485039A (en) *	1982-06-11	1984-11-27	University Patents, Inc.	Synthetic analogues of α-melanotropin
DE3623019A1 (de) *	1986-07-09	1988-01-21	Dieter Prof Dr Dr Aderhold	Melanotropin als therapeutischer wirkstoff

1987
- 1987-01-23 WO PCT/US1987/000226 patent/WO1987004623A1/en active IP Right Grant
- 1987-01-23 DE DE8787901815T patent/DE3783541T2/de not_active Expired - Lifetime
- 1987-01-23 AT AT87901815T patent/ATE84420T1/de not_active IP Right Cessation
- 1987-01-23 EP EP87901815A patent/EP0259440B1/en not_active Expired - Lifetime
- 1987-01-23 AU AU70828/87A patent/AU597630B2/en not_active Expired
- 1987-01-23 KR KR1019870700899A patent/KR900005903B1/ko not_active IP Right Cessation
- 1987-01-29 IE IE23687A patent/IE60883B1/en not_active IP Right Cessation
- 1987-02-03 CA CA000528829A patent/CA1282324C/en not_active Expired - Lifetime
- 1987-02-03 NZ NZ233248A patent/NZ233248A/xx unknown
- 1987-10-02 DK DK518187A patent/DK518187A/da not_active Application Discontinuation
1988
- 1988-02-11 US US07/154,823 patent/US4918055A/en not_active Expired - Lifetime
- 1988-07-22 US US07/224,187 patent/US4866038A/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
WO1987004623A1 (en)	1987-08-13
US4866038A (en)	1989-09-12
DE3783541T2 (de)	1993-06-17
AU597630B2 (en)	1990-06-07
US4918055A (en)	1990-04-17
EP0259440A4 (en)	1989-11-07
ATE84420T1 (de)	1993-01-15
CA1282324C (en)	1991-04-02
KR900005903B1 (ko)	1990-08-16
EP0259440A1 (en)	1988-03-16
DE3783541D1 (de)	1993-02-25
AU7082887A (en)	1987-08-25
IE870236L (en)	1987-08-03
EP0259440B1 (en)	1993-01-13
IE60883B1 (en)	1994-08-24
DK518187A (da)	1987-12-02
NZ233248A (en)	1993-01-27
DK518187D0 (da)	1987-10-02

Publication	Publication Date	Title
KR880700670A (ko)	1988-04-11	알파-msh의 동족체의 국소적용으로 메라노싸이트를 자극시키는 방법 및 이에 사용될 수 있는 조성물
DE3750275D1 (de)	1994-09-01	Lackzusammensetzung und -anwendung.
DE3684437D1 (de)	1992-04-23	Hautmarkierungsmittel.
DE3688895D1 (de)	1993-09-23	Kosmetisches mittel.
NO872596L (no)	1987-12-28	Organopolysiloksanblandinger og anvendelse derav for impregnering.
DE3582894D1 (de)	1991-06-27	Hautbehandlungsmittel.
ES2017922B3 (es)	1991-03-16	3-amino-4,5-dihidroxipiperidinas, procedimiento para su preparacion, y su empleo.
DK90089D0 (da)	1989-02-24	Hudbehandlingspraeparat
DE3675752D1 (de)	1991-01-03	Konservierungsmittelzusammensetzung.
IT8622795A0 (it)	1986-12-19	Metodo per un efficace trattamento idratante della pelle, particolarmente per applicazione in campo cosmetico.
IT8419076A0 (it)	1984-01-09	Composizione cosmetica a base di glicoproteine per il trattamento della pelle.
DK215983A (da)	1983-11-16	Praeparater til hudpleje
IS3286A7 (is)	1988-05-21	Súr efnablanda til nota í brauð
DK244286A (da)	1987-11-24	Eldaase til montering i kasbelskinne
NO872597D0 (no)	1987-06-22	Organopolysiloksanblandinger og anvendelse derav for impregnering.
DK400487A (da)	1988-02-02	Transdermale praeparater
NO165421C (no)	1991-02-13	Fremgangsmaate og anordning for avskinning.
DE3674997D1 (de)	1990-11-22	Holzbehandlungszusammensetzung.
DK674587A (da)	1987-12-21	Anti-forkoelelses-kit, anti-forkoelelsespraeparat og anvendelse deraf
ATE63685T1 (de)	1991-06-15	Hautbehandlungsmittel.
ATE57458T1 (de)	1990-11-15	Holzbehandlungszusammensetzung.
NO874962L (no)	1988-01-22	Totrinnsmetode for indolent saarheling og vandig medium og topisk salve benyttet i denne forbindelse.
ATE76281T1 (de)	1992-06-15	Haarbehandlungsmittel.
IT8324322A0 (it)	1983-12-22	Metodo e composizione per il trattamento topico di alcune patologiche cutanee.
IT8644011A0 (it)	1986-09-15	Detensore cutaneo

Legal Events

Date	Code	Title	Description
1987-10-03	A201	Request for examination
1987-10-03	PA0109	Patent application	Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 19871003
1987-10-03	PA0201	Request for examination	Patent event code: PA02012R01D Patent event date: 19871003 Comment text: Request for Examination of Application
1988-04-11	PG1501	Laying open of application
1990-04-30	E902	Notification of reason for refusal
1990-04-30	PE0902	Notice of grounds for rejection	Comment text: Notification of reason for refusal Patent event date: 19900430 Patent event code: PE09021S01D
1990-07-16	G160	Decision to publish patent application
1990-08-16	PG1605	Publication of application before grant of patent	Comment text: Decision on Publication of Application Patent event code: PG16051S01I Patent event date: 19900716
1990-11-15	E701	Decision to grant or registration of patent right
1990-11-15	PE0701	Decision of registration	Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 19901115
1991-02-04	GRNT	Written decision to grant
1991-02-04	PR0701	Registration of establishment	Comment text: Registration of Establishment Patent event date: 19910204 Patent event code: PR07011E01D
1991-02-04	PR1002	Payment of registration fee	Payment date: 19910204 End annual number: 3 Start annual number: 1
1993-08-12	PR1001	Payment of annual fee	Payment date: 19930812 Start annual number: 4 End annual number: 4
1994-08-12	PR1001	Payment of annual fee	Payment date: 19940812 Start annual number: 5 End annual number: 5
1995-08-11	PR1001	Payment of annual fee	Payment date: 19950811 Start annual number: 6 End annual number: 6
1996-08-02	PR1001	Payment of annual fee	Payment date: 19960802 Start annual number: 7 End annual number: 7
1997-08-12	PR1001	Payment of annual fee	Payment date: 19970812 Start annual number: 8 End annual number: 8
1998-08-11	PR1001	Payment of annual fee	Payment date: 19980811 Start annual number: 9 End annual number: 9
1999-08-05	PR1001	Payment of annual fee	Payment date: 19990805 Start annual number: 10 End annual number: 10
2000-08-11	PR1001	Payment of annual fee	Payment date: 20000811 Start annual number: 11 End annual number: 11
2001-08-08	PR1001	Payment of annual fee	Payment date: 20010808 Start annual number: 12 End annual number: 12
2002-08-06	PR1001	Payment of annual fee	Payment date: 20020806 Start annual number: 13 End annual number: 13
2003-08-06	PR1001	Payment of annual fee	Payment date: 20030806 Start annual number: 14 End annual number: 14
2004-08-09	PR1001	Payment of annual fee	Payment date: 20040809 Start annual number: 15 End annual number: 15
2005-08-09	PR1001	Payment of annual fee	Payment date: 20050809 Start annual number: 16 End annual number: 16
2006-08-10	FPAY	Annual fee payment	Payment date: 20060810 Year of fee payment: 17
2006-08-10	PR1001	Payment of annual fee	Payment date: 20060810 Start annual number: 17 End annual number: 17
2007-01-24	EXPY	Expiration of term
2007-01-24	PC1801	Expiration of term